Cravens & Co Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$998K	Buy	2,241 +63	+3%	+$28K	0.74%	31
2025 Q1	$1.06M	Buy	2,178 +16	+0.7%	+$7.76K	0.82%	27
2024 Q4	$871K	Sell	2,162 -46	-2%	-$18.5K	0.66%	31
2024 Q3	$1.03M	Sell	2,208 -68	-3%	-$31.6K	0.79%	26
2024 Q2	$1.07M	Buy	+2,276	New	+$1.07M	0.79%	29